Tonghua Dongbao Pharmaceutical Co Ltd (600867) — Capital Reinvestment Ratio
Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Capital Reinvestment Ratio of 2.39x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥62.99 Million) in capital expenditures (CN¥150.58 Million). See 600867 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tonghua Dongbao Pharmaceutical Co Ltd Capital Reinvestment Ratio (2000–2025)
This chart tracks Tonghua Dongbao Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 25 annual periods.
Annual Capital Reinvestment Ratio for Tonghua Dongbao Pharmaceutical Co Ltd (2000–2025)
Year-by-year Capital Reinvestment Ratio for Tonghua Dongbao Pharmaceutical Co Ltd from 2000 to 2025. For live market cap and broader valuation context, see Tonghua Dongbao Pharmaceutical Co Ltd (600867) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.75x | CN¥689.23 Million | CN¥517.69 Million | ▼ -39.3% |
| 2024 | 1.24x | CN¥459.74 Million | CN¥568.73 Million | ▲ +206.1% |
| 2023 | 0.40x | CN¥861.52 Million | CN¥348.13 Million | ▼ -29.1% |
| 2022 | 0.57x | CN¥863.09 Million | CN¥491.63 Million | ▲ +7.6% |
| 2021 | 0.53x | CN¥1.13 Billion | CN¥600.75 Million | ▲ +31.6% |
| 2020 | 0.40x | CN¥1.19 Billion | CN¥479.59 Million | ▲ +58.1% |
| 2019 | 0.25x | CN¥1.15 Billion | CN¥293.13 Million | ▼ -71.1% |
| 2018 | 0.88x | CN¥876.94 Million | CN¥773.07 Million | ▲ +356.8% |
| 2017 | 0.19x | CN¥961.19 Million | CN¥185.50 Million | ▼ -66.0% |
| 2016 | 0.57x | CN¥725.76 Million | CN¥411.53 Million | ▼ -58.3% |
| 2015 | 1.36x | CN¥294.58 Million | CN¥400.09 Million | ▲ +163.6% |
| 2014 | 0.52x | CN¥205.89 Million | CN¥106.08 Million | ▼ -40.2% |
| 2013 | 0.86x | CN¥221.06 Million | CN¥190.36 Million | ▼ -30.8% |
| 2012 | 1.24x | CN¥194.32 Million | CN¥241.83 Million | ▲ +174.7% |
| 2010 | 0.45x | CN¥160.40 Million | CN¥72.66 Million | ▼ -4.8% |
| 2009 | 0.48x | CN¥166.20 Million | CN¥79.07 Million | ▼ -22.5% |
| 2008 | 0.61x | CN¥92.31 Million | CN¥56.67 Million | ▼ -71.3% |
| 2007 | 2.14x | CN¥120.94 Million | CN¥258.34 Million | ▲ +17.6% |
| 2006 | 1.82x | CN¥158.00 Million | CN¥286.90 Million | ▲ +40.3% |
| 2005 | 1.29x | CN¥92.23 Million | CN¥119.38 Million | ▼ -65.3% |
| 2004 | 3.73x | CN¥13.17 Million | CN¥49.08 Million | ▲ +193.0% |
| 2003 | 1.27x | CN¥45.51 Million | CN¥57.90 Million | ▼ -54.5% |
| 2002 | 2.79x | CN¥31.99 Million | CN¥89.41 Million | ▲ +270.9% |
| 2001 | 0.75x | CN¥117.73 Million | CN¥88.69 Million | ▼ -58.2% |
| 2000 | 1.80x | CN¥29.12 Million | CN¥52.46 Million | — |